Andy Richards

Biotechnology Entrepreneur and Business Angel

Arecor, Congenica, Abcodia, Closed Loop Medicine, The Babraham Research Campus

Dr Andy Richards CBE is an entrepreneur and investor with an established track record in founding and scaling up innovative Biotech and Healthtech companies in the UK. He is Chairman of Arecor, Congenica, Abcodia, Closed Loop Medicine and The Babraham Research Campus and is a Director of Silence Therapeutics plc, Ieso Digital Health Ltd, and Owlstone Medical. He is also a director of Cancer Research Technology, a member of CRUK and on the advisory board of the CRUK Early Detection Centre. He is an advisor to several investment funds. He is a Cambridge graduate with a PhD in Chemistry and an early career spanning positions with ICI
(now AstraZeneca) and PA Technology. He was a founder and executive director of Chiroscience plc until its merger with Celltech in 1999 and since that time he has founded, invested in and helped to scale more than 25 innovative ventures. He is also a founder member of the Cambridge Angels, and received a CBE for services to life science investment in 2015.